Loading...
Resources2019-01-29T22:20:33+00:00

Lung Cancer is complex and can seem overwhelming at times. Below are resources that we hope will help you make sense of it all. Research -Survivor Support- Advocacy.

SFAC is working to change attitudes and perceptions about lung cancer through inspiring survivor stories and a vibrant running community. No days off until we have a cure!

The more you know!

What is the leading cause of lung cancer among non smokers?2018-12-20T01:29:41+00:00

According to the United States Environmental Protection Agency (EPA), radon gas is the leading cause of lung cancer among non smokers.  Overall, radon is the second leading cause of lung cancer.  Radon is responsible for nearly 21,000 lung cancer deaths annually (2,900 of these are among people who have never smoked).

 

Learn more about radon testing at: http://sosradon.org/test-kits

https://www.epa.gov/radon/health-risk-radon

 

What are your chances of being diagnosed with lung cancer?2019-01-16T22:09:12+00:00

According to the Lung Cancer Foundation, your chances of being diagnosed in your lifetime is about 1 in 15 (men- 1 in 14 and women- 1 in 17).

 

http://seer.cancer.gov/csr/1975_2012/results_merged/sect_15_lung_bronchus.pdf Tables 15.18-15.20

T or F- African American men are at higher risk than Caucasian men?2018-12-20T01:32:59+00:00

TRUE.  The probability of an African American man developing lung cancer is nearly 40 times greater than their Caucasian counterparts.  However, there is no significant difference between African American and Caucasian women.

 

https://seer.cancer.gov/statfacts/html//common.html

In the U.S., how many people will die this year from lung cancer?2018-12-20T01:31:07+00:00

According to the federal government, Lung cancer will claim 154,050 lives this year, more than three times the 50,630 deaths from the second cancer killer- colorectal cancer.

https://seer.cancer.gov/statfacts/html//common.html

T or F- More women die from breast cancer than from lung cancer.2019-01-16T22:12:58+00:00

FALSE.  Over their lifetime, women are 82% more likely to die from lung cancer than from breast cancer.

 

http://seer.cancer.gov/csr/1975_2012/results_merged/sect_01_overview.pdf Table 1.20

How many people are killed daily by lung cancer?2018-12-20T01:34:15+00:00

Lung cancer claims approximately 422 lives every day.  That is more than the seating capacity of a Boeing 747-400.

 

https://seer.cancer.gov/statfacts/html//common.html

http://www.boeing.com/commercial/747

Have a question?

Resources and useful links

Links to helpful information and organizations

We are constantly looking for the latest information to share.  Please submit any articles or stories here.

  • 1/03/2019 New England Journal of Medicine: Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
    Summary: Supplementation with vitamin D did not result in a lower incidence of invasive cancer or cardiovascular events than placebo. (Funded by the National Institutes of Health and others; VITAL ClinicalTrials.gov number, NCT01169259.) Read the full article here.

  • 12/13/2018 CURE (www.curetoday.com): Immunotherapy Side Effects May Be More Prevalent in Real World Than in Studies
    Summary: Some side effects of immunotherapy could are under-reported when drugs are in clinical trials. Read the full article here.

  • 12/13/2018 New England Journal of Medicine: Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
    Summary: Durvalumab therapy resulted in significantly longer overall survival than placebo. No new safety signals were identified. (Funded by AstraZeneca; PACIFIC ClinicalTrials.gov number, NCT02125461.) Read the full article here.

  • 12/06/2018 New England Journal of Medicine: First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
    Summary: The addition of atezolizumab to chemotherapy in the first-line treatment of extensive-stage small-cell lung cancer resulted in significantly longer overall survival and progression-free survival than chemotherapy alone. (Funded by F. Hoffmann–La Roche/Genentech; IMpower133 ClinicalTrials.gov number, NCT02763579.) Read the full article here.

  • 11/22/2018  New England Journal of Medicine: Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
    Summary: In patients with previously untreated metastatic, squamous NSCLC, the addition of pembrolizumab to chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel resulted in significantly longer overall survival and progression-free survival than chemotherapy alone. (Funded by Merck Sharp & Dohme; KEYNOTE-407 ClinicalTrials.gov number, NCT02775435.) Read the full article here.

  • 12/18/2018 CURE (www.curetoday.com): Billionaire Philanthropist Discusses His Institute’s Work to Perfect Cancer Immunotherapy
    Summary: Interview with Sean Parker who was President of Facebook at age 24. Now, 15 years later, he has directed a portion of his social media wealth and a significant amount of his time and passion to the cause of fighting cancer through immunotherapy. Read the full article/interview here.

  • 10/30/2018 CURE (www.curetoday.com): FDA Approves Keytruda Combination for Non-Small Cell Lung Cancer Subset
    Summary: Merck’s Keytruda continues to win favor and extend lives. FDA grants broader use of the drug for NSCLC. Read the full article here.

Join the Streak Force!

Get in touch!
Pledge Your Support!

Our Mission

SFAC is working to change attitudes and perceptions about lung cancer through inspiring survivor stories and a vibrant running community. No days off, until we find a cure!